ViperaTAb (BTG)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameViperaTAb (BTG)
Drug Alias NameCommon adder antivenom ViperaTAb - ProthericsViperaTAb
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragmentBiologics > Protein drugs > Toxin
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPoisoning
Global Approved IndicationsPoisoning
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1993/01/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBtg Plc
China Registration ClassN/A

Develop Information

Active CompaniesBtg Plc
Inactive CompaniesN/A
Active IndicationsPoisoning
Inactive IndicationsN/A

Other Information

ATC CodeL01XC
Related LinksN/A